Medical Case Management Market
Medical Case Management Market
Press Release

According to a new market research study titled ‘Human Microbiome Market to 2025 – Global Analysis and Forecasts by Product, Disease and Application. The global human microbiome market is expected to reach US$ 1,197.08 Mn in 2025 from US$ 257.30 Mn in 2017. The market is estimated to grow with a CAGR of 21.8% from 2018-2025. The report highlights the trends prevalent in the global human microbiome market and the factors driving the market along with those that act as deterrents to its growth.

The product segment of the human microbiome market is broadly segmented into food, medical foods, probiotics, prebiotics, drugs, diagnostic devices and supplements. In 2017, the probiotics segment held the largest share of the market, by product. However, the prebiotics is expected to grow at the fastest CAGR during the forecast period owing to growing demand for fiber rich food products is expected to drive the market. Additionally, rising investment in the food & beverage industry for innovation and development of new food products enriched with prebiotics.

Get sample PDF copy of this Study: https://www.theinsightpartners.com/sample/TIPBT00002233/

The market for human microbiome is expected to grow as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies and growing technological advancements in metagenomics and next-generation sequencing are expected to fuel the market growth during the forecast period. In addition, the human microbiome – a new frontier in drug discovery is likely to have a positive impact on the growth of the market in the coming years.

The major players operating in the human microbiome market include Enterome, MicroBiome Therapeutics, LLC, Rebiotix Inc., Yakult Honsha Co., Ltd., Osel Inc., Vedanta Biosciences, Inc., Metabiomics Corporate, Synthetic Biologics, Inc., DuPont, and BiomX Ltd. For instance, in April 2018, MicroBiome Therapeutics, LLC (MBT), announced the launch of BiomeBliss, a patented, first-in-class prebiotic dietary supplement specifically developed to support a healthy gastrointestinal (GI) microbiome. Developed by pioneering researchers and entrepreneurs, BiomeBliss nourishes, shifts and protects the GI microbiome ? the trillions of gut bacteria that affect health. The developments performed by the companies are helping the market to grow in the coming years.

The global human microbiome market by product was led by probiotics segment. In 2017, the probiotics segment held a largest market share of 24.7% of the human microbiome market, by product. The probiotics segment is expected to dominate the market in 2025, due to increasing health concerns, growing awareness regarding the relation of nutrition, diet, and health, and increasing probiotics market penetration in dairy and other food and beverages industry is expected to favor the overall demand.

Purchase This Report @ https://www.theinsightpartners.com/buy/TIPBT00002233/

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Semiconductors, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: [email protected]

This post was originally published on The Picayune Current